(The new advisory panel includes several members with ties to the peptides industry, raising concerns about its impartiality.) After the first day of deliberation, the panel voted in favor of easing restrictions on two popular peptidesBPC-157 and KPVdespite the fact that other FDA scientists have publicly raised concerns about the lack of evidence for these compounds
Combined, the two peptides address healing from several angles at once
Furthermore, evidence in the rats has so far shown the recovery of the various muscle disabilities deriving from a multitude of different causes, peripheral and central, given that muscle weakness was part of the primary disturbance that was also attenuated
But I also know what I want: more energy, less brain fog and noise, a body I can actually live in
The pen does the math for you
Naloxone and other reversal agents are an example of a harm reduction approach